Profiles for companies starting with 'm'
✉ Email this page to a colleague
Drugs and US Patents for m
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meitheal | PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 215698-001 | Jul 24, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Marshall Pharma | RESERPINE | reserpine | TABLET;ORAL | 080492-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Micro Labs | CELECOXIB | celecoxib | CAPSULE;ORAL | 204776-002 | Apr 30, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Merck Sharp Dohme | WELIREG | belzutifan | TABLET;ORAL | 215383-001 | Aug 13, 2021 | RX | Yes | Yes | 12,358,870 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
